Published in Managed Care Business Week, March 6th, 2007
The agreement involves several products including the antibiotic Monuril, the mucolytic Fluimicil, the antibiotic Lorafem and the anti-infective Panotile Cipro.
As part of this agreement, Laboratoires Pierre Fabre will be strengthening its network by absorbing Zambon's specialist medical sales force in the country to provide complete coverage of key physicians and pharmacists across Germany. The agreement will thus ensure the most effective possible support for the innovative Zambon portfolio, which...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Managed Care Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.